Product NewsGyros Protein Technologies Introduces Gyrolab Bioaffy 4000 CD to Extend Sensitivity of Immunoassay CD Rangeby Gyros Protein TechnologiesEnables researchers to generate more data in less time to support both preclinical and clinical studies
Product NewsGyros Protein Technologies Introduces Gyrolab AAVX Titer Kit to Support Cell and Gene Therapy Marketby Gyros Protein Technologies Ready-to-use kit enables rapid adeno-associated virus (AAV) titer determinations during the manufacture of AAV vectors
Product NewsGyros Protein Technologies Introduces Gyrolab p24 Kit to Support the Cell and Gene Therapy Marketby Gyros Protein TechnologiesReady-to-use kit enables lentivirus titer determinations during the manufacture of lentivirus vectors
Product NewsGyros Protein Technologies Introduces PurePep Chorus Automated Peptide Synthesizerby Gyros Protein TechnologiesFlexible, modular system, designed for 21CFR Part 11 compliance
Product NewsGyros Protein Technologies Introduces Gyrolab CHO-HCP E3G Kit for Impurity Testing of Biotherapeuticsby Gyros Protein TechnologiesReady-to-use immunoassay kit designed to increase productivity
Gyros Protein Technologies and Cygnus Technologies Sign Licensing and Supply Agreementby Gyros Protein Technologies,Cygnus TechnologiesGyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents
Product NewsGyros Protein Technologies Introduces the Gyrolab xPandby Gyros Protein TechnologiesNew platform aims to improve immunoassay workflow, flexibility, and speed in biotherapeutic discovery, development, and production
Product NewsGyros Protein Technologies Introduces Multi-Species Kit for Toxicokinetic Studiesby Gyros Protein TechnologiesGyrolab Generic TK Kit for early-stage biotherapeutic development, optimized for use in Gyrolab systems